In addition, analysis of gene signatures in human cancers indicates that high DDX3 expression correlates with shorter overall survival in NSCLC (Supplementary Fig S1) (Bild et al, 2006). This evidence concerns the gene DDX3X and non-small cell lung carcinoma.